Pfizer signs antiviral COVID-19 licence with MPP

Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool (MPP) to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID (PF-07321332) for low and middle-income countries.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

BMS, Pfizer win patent dispute over blockbuster drug, Eliquis

6 September 2021 In a victory for Bristol-Myers Squibb and Pfizer, the US Court of Appeals for the Federal Circuit has affirmed the validity of a pair of patents covering blood clot treatment, Eliquis.

Big Pharma

Pfizer drops Xeljanz patent suits

20 April 2021 Pfizer has settled lawsuits against two Indian generics makers who had informed the US Food and Drug Administration of plans to launch their own version of Xeljanz XR.

Americas

Pfizer claims employee stole COVID-19 vaccine documents

25 November 2021 Pfizer is currently investigating a soon-to-be former employee who it believes has transferred more than 12,000 files, many of which contain confidential and trade secret information, to her personal devices and has repeatedly attempted to cover her tracks.

More on this story

Americas

BMS, Pfizer win patent dispute over blockbuster drug, Eliquis

Big Pharma

Pfizer drops Xeljanz patent suits

20 April 2021 Pfizer has settled lawsuits against two Indian generics makers who had informed the US Food and Drug Administration of plans to launch their own version of Xeljanz XR.

Americas

Pfizer claims employee stole COVID-19 vaccine documents

More on this story

Americas

BMS, Pfizer win patent dispute over blockbuster drug, Eliquis

Big Pharma

Pfizer drops Xeljanz patent suits

20 April 2021 Pfizer has settled lawsuits against two Indian generics makers who had informed the US Food and Drug Administration of plans to launch their own version of Xeljanz XR.

Americas

Pfizer claims employee stole COVID-19 vaccine documents